Scarica l'app Stockscreener
8.70
2.73%
-0.40
Dopo l'orario di chiusura:
8.70
Precedente Chiudi:
$9.10
Aprire:
$9.07
Volume 24 ore:
57,225
Relative Volume:
0.49
Capitalizzazione di mercato:
$5.07M
Reddito:
$49,300
Utile/perdita netta:
$-6.27M
Rapporto P/E:
-0.9571
EPS:
-9.09
Flusso di cassa netto:
$-5.38M
1 W Prestazione:
+5.00%
1M Prestazione:
+15.40%
6M Prestazione:
-2.73%
1 anno Prestazione:
+92.84%
Intervallo 1D:
$8.5301
$9.10
Intervallo di 1 settimana:
$7.60
$12.03
Portata 52W:
$0.7425
$562.68
Aclarion Inc Stock (ACON) Company Profile
Nome
Aclarion Inc
Settore
Industria
Telefono
833 275 2266
Indirizzo
8181 ARISTA PLACE, BROOMFIELD
Confronta ACON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
8.70 | 5.21M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
292.93 | 47.15B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
91.02 | 15.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.30 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
91.04 | 8.10B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.81 | 6.99B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc Borsa (ACON) Ultime notizie
Is it time to cut losses on Aclarion Inc. Equity Warrant2025 Trade Ideas & Weekly Hot Stock Watchlists - newser.com
Will Aclarion Inc. Equity Warrant continue its uptrendCPI Data & Low Volatility Stock Recommendations - newser.com
Why Aclarion Inc. Equity Warrant stock is favored by top institutionsDay Trade & Stepwise Swing Trade Plans - newser.com
Pattern recognition hints at Aclarion Inc. Equity Warrant upsideEntry Point & Free Verified High Yield Trade Plans - newser.com
Is Aclarion Inc. stock ready for a breakoutWeekly Trade Report & Weekly Breakout Opportunity Watchlist - newser.com
Risk vs reward if holding onto Aclarion Inc. Equity WarrantMarket Performance Recap & Safe Entry Momentum Tips - newser.com
Why Aclarion Inc. Equity Warrant stock could rally in 2025Quarterly Earnings Report & Consistent Profit Trading Strategies - newser.com
What MACD signals say about Aclarion Inc.Weekly Trade Analysis & Safe Swing Trade Setups - newser.com
How geopolitical risks impact Aclarion Inc. (IT20) stock2025 Investor Takeaways & Weekly Consistent Profit Watchlists - newser.com
What technical models suggest about Aclarion Inc.’s comebackPortfolio Performance Summary & Community Trade Idea Sharing - newser.com
Does Aclarion Inc. Equity Warrant show high probability of reboundWeekly Gains Summary & Long-Term Capital Growth Ideas - newser.com
Aclarion Announces Securities Purchase Agreement for $2.5M - TipRanks
Aclarion IncClarity Trial On Schedule, Early Readouts Expected Q2 2026 - TradingView
Aclarion, Inc. Reports Strong Financial Position and Record Growth in Nociscan Utilization Amid Ongoing CLARITY Trial Progress - Quiver Quantitative
Aclarion reports 89% increase in Nociscan scan volumes in Q3 - Investing.com
Aclarion Provides Corporate Update Highlighting Market Expansion as CLARITY Trial Advances Toward Key Data Catalyst - The Manila Times
Why Ericsson Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Aclarion (NASDAQ:ACON) Stock Price Up 12.7% – What’s Next? - Defense World
Will Aclarion Inc. Equity Warrant stock benefit from infrastructure spendingJuly 2025 Update & High Accuracy Trade Alerts - newser.com
Technical analysis overview for Aclarion Inc. stockChart Signals & Verified Short-Term Plans - newser.com
Aclarion Inc Stock Analysis and ForecastInsider Selling Patterns & Invest Now – Opportunity Window Closing - earlytimes.in
Aclarion Stock Rises 32% After Global Pain Conference Presentation - Nasdaq
Aclarion stock soars after participation in international pain meeting - Investing.com
Aclarion stock soars after participation in international pain meeting By Investing.com - Investing.com Australia
Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference - Ortho Spine News
Tools to assess Aclarion Inc. Equity Warrant’s risk profile2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
Is this a good reentry point in Aclarion Inc. Equity Warrant2025 Biggest Moves & Real-Time Sentiment Analysis - newser.com
Why hedge funds are buying Aclarion Inc. stockDividend Hike & Smart Money Movement Alerts - newser.com
Regression analysis insights on Aclarion Inc. performanceJuly 2025 Opening Moves & Advanced Technical Signal Analysis - newser.com
Morning Market Movers: PMAX, STI, GWH, ACON See Big Swings - RTTNews
266M with low back pain — Aclarion Nociscan MR spectroscopy + AI identifies painful discs at ISPN - Stock Titan
Will Aclarion Inc. Equity Warrant stock recover faster than peersEarnings Risk Summary & AI Forecast for Swing Trade Picks - newser.com
Why NioCorp Developments Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
What drives Aclarion Inc Equity Warrant stock priceMarket Sentiment Indicators & Superior Capital Trading - earlytimes.in
Can trapped investors hope for a rebound in Aclarion Inc.Weekly Investment Recap & Fast Gain Stock Trading Tips - newser.com
Why Aclarion Inc. stock attracts high net worth investors2025 Dividend Review & Weekly Setup with ROI Potential - newser.com
Published on: 2025-10-10 06:02:50 - newser.com
Live market analysis of Aclarion Inc. Equity WarrantWeekly Volume Report & Safe Capital Growth Trade Ideas - newser.com
Published on: 2025-10-10 05:09:35 - newser.com
What machine learning models say about Aclarion Inc. Equity WarrantTake Profit & Verified Momentum Stock Ideas - newser.com
Can Aclarion Inc. stock resist sector downturnsTrade Performance Summary & Verified High Yield Trade Plans - newser.com
Aclarion Inc Azioni (ACON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.69%
2.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):